SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors

Michael B. Plewe, Landon R. Whitby, Shibani Naik, Eric R. Brown, Nadezda V. Sokolova, Vidyasagar Reddy Gantla, Joanne York, Jack H. Nunberg, Lihong Zhang, Birte Kalveram, Alexander Freiberg, Dale L. Boger, Greg Henkel, Ken McCormack

Research output: Contribution to journalArticle

Abstract

Old World (Africa) and New World (South America) arenaviruses are associated with human hemorrhagic fevers. Efforts to develop small molecule therapeutics have yielded several chemical series including the 4-acyl-1,6-dialkylpiperazin-2-ones. Herein, we describe an extensive exploration of this chemotype. In initial Phase I studies, R1 and R4 scanning libraries were assayed to identify potent substituents against Old World (Lassa) virus. In subsequent Phase II studies, R6 substituents and iterative R1, R4 and R6 substituent combinations were evaluated to obtain compounds with improved Lassa and New World (Machupo, Junin, and Tacaribe) arenavirus inhibitory activity, in vitro human liver microsome metabolic stability and aqueous solubility.

Original languageEnglish (US)
Article number126620
JournalBioorganic and Medicinal Chemistry Letters
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Arenavirus
Viruses
Liver
Lassa virus
Solubility
Scanning
Molecules
South America
Liver Microsomes
Libraries
Fever
Therapeutics

Keywords

  • Arenavirus
  • Entry inhibitor
  • Junin
  • Lassa
  • Machupo
  • Piperazinone

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Plewe, M. B., Whitby, L. R., Naik, S., Brown, E. R., Sokolova, N. V., Gantla, V. R., ... McCormack, K. (Accepted/In press). SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors. Bioorganic and Medicinal Chemistry Letters, [126620]. https://doi.org/10.1016/j.bmcl.2019.08.024

SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors. / Plewe, Michael B.; Whitby, Landon R.; Naik, Shibani; Brown, Eric R.; Sokolova, Nadezda V.; Gantla, Vidyasagar Reddy; York, Joanne; Nunberg, Jack H.; Zhang, Lihong; Kalveram, Birte; Freiberg, Alexander; Boger, Dale L.; Henkel, Greg; McCormack, Ken.

In: Bioorganic and Medicinal Chemistry Letters, 01.01.2019.

Research output: Contribution to journalArticle

Plewe, MB, Whitby, LR, Naik, S, Brown, ER, Sokolova, NV, Gantla, VR, York, J, Nunberg, JH, Zhang, L, Kalveram, B, Freiberg, A, Boger, DL, Henkel, G & McCormack, K 2019, 'SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors', Bioorganic and Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2019.08.024
Plewe, Michael B. ; Whitby, Landon R. ; Naik, Shibani ; Brown, Eric R. ; Sokolova, Nadezda V. ; Gantla, Vidyasagar Reddy ; York, Joanne ; Nunberg, Jack H. ; Zhang, Lihong ; Kalveram, Birte ; Freiberg, Alexander ; Boger, Dale L. ; Henkel, Greg ; McCormack, Ken. / SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors. In: Bioorganic and Medicinal Chemistry Letters. 2019.
@article{e49cb34bd7734427bc9420a2af98c33d,
title = "SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors",
abstract = "Old World (Africa) and New World (South America) arenaviruses are associated with human hemorrhagic fevers. Efforts to develop small molecule therapeutics have yielded several chemical series including the 4-acyl-1,6-dialkylpiperazin-2-ones. Herein, we describe an extensive exploration of this chemotype. In initial Phase I studies, R1 and R4 scanning libraries were assayed to identify potent substituents against Old World (Lassa) virus. In subsequent Phase II studies, R6 substituents and iterative R1, R4 and R6 substituent combinations were evaluated to obtain compounds with improved Lassa and New World (Machupo, Junin, and Tacaribe) arenavirus inhibitory activity, in vitro human liver microsome metabolic stability and aqueous solubility.",
keywords = "Arenavirus, Entry inhibitor, Junin, Lassa, Machupo, Piperazinone",
author = "Plewe, {Michael B.} and Whitby, {Landon R.} and Shibani Naik and Brown, {Eric R.} and Sokolova, {Nadezda V.} and Gantla, {Vidyasagar Reddy} and Joanne York and Nunberg, {Jack H.} and Lihong Zhang and Birte Kalveram and Alexander Freiberg and Boger, {Dale L.} and Greg Henkel and Ken McCormack",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.bmcl.2019.08.024",
language = "English (US)",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors

AU - Plewe, Michael B.

AU - Whitby, Landon R.

AU - Naik, Shibani

AU - Brown, Eric R.

AU - Sokolova, Nadezda V.

AU - Gantla, Vidyasagar Reddy

AU - York, Joanne

AU - Nunberg, Jack H.

AU - Zhang, Lihong

AU - Kalveram, Birte

AU - Freiberg, Alexander

AU - Boger, Dale L.

AU - Henkel, Greg

AU - McCormack, Ken

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Old World (Africa) and New World (South America) arenaviruses are associated with human hemorrhagic fevers. Efforts to develop small molecule therapeutics have yielded several chemical series including the 4-acyl-1,6-dialkylpiperazin-2-ones. Herein, we describe an extensive exploration of this chemotype. In initial Phase I studies, R1 and R4 scanning libraries were assayed to identify potent substituents against Old World (Lassa) virus. In subsequent Phase II studies, R6 substituents and iterative R1, R4 and R6 substituent combinations were evaluated to obtain compounds with improved Lassa and New World (Machupo, Junin, and Tacaribe) arenavirus inhibitory activity, in vitro human liver microsome metabolic stability and aqueous solubility.

AB - Old World (Africa) and New World (South America) arenaviruses are associated with human hemorrhagic fevers. Efforts to develop small molecule therapeutics have yielded several chemical series including the 4-acyl-1,6-dialkylpiperazin-2-ones. Herein, we describe an extensive exploration of this chemotype. In initial Phase I studies, R1 and R4 scanning libraries were assayed to identify potent substituents against Old World (Lassa) virus. In subsequent Phase II studies, R6 substituents and iterative R1, R4 and R6 substituent combinations were evaluated to obtain compounds with improved Lassa and New World (Machupo, Junin, and Tacaribe) arenavirus inhibitory activity, in vitro human liver microsome metabolic stability and aqueous solubility.

KW - Arenavirus

KW - Entry inhibitor

KW - Junin

KW - Lassa

KW - Machupo

KW - Piperazinone

UR - http://www.scopus.com/inward/record.url?scp=85072213465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072213465&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2019.08.024

DO - 10.1016/j.bmcl.2019.08.024

M3 - Article

AN - SCOPUS:85072213465

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

M1 - 126620

ER -